BioXcel Therapeutics Cash Flow Statement (2022-2025) | BTAI

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -31.47M-37.67M-41.87M-54.33M-52.55M-54.05M-50.48M-22.36M-26.82M-20.32M-18.47M-14.16M-13.81M-19.84M-18.36M
Depreciation and Depletion 0.08M0.08M0.09M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.07M0.07M
Share-based Compensation 3.83M4.48M4.48M4.55M4.88M6.12M4.01M3.60M3.43M1.06M1.86M-0.20M0.18M1.56M0.58M
Gains from Sales and Divestitures 220.000.03M0.06M0.06M0.07M0.06M0.07M0.04M0.01M0.01M0.02M
Gains from Investment Securities 0.12M0.12M-0.34M0.03M0.23M4.85M0.05M0.00M0.02M
Non-cash Items 22.84M21.44M18.07M15.48M3.11M3.21M3.38M9.48M3.66M4.36M3.90M7.69M0.26M1.06M0.68M
Cash from Operations -32.41M-33.10M-31.19M-38.64M-52.35M-38.21M-37.58M-26.86M-17.71M-23.17M-16.34M-14.81M-12.04M-12.57M-18.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.08M
Amortization of Deferred Charges 0.32M0.22M0.32M0.40M0.36M0.38M0.66M1.22M0.10M0.11M2.72M2.67M0.39M0.44M
Depreciation & Amortization (CF) 0.08M0.08M0.09M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.07M0.07M
Change in Working Capital
Change in Receivables 0.04M0.15M0.30M-0.66M0.31M0.43M-0.81M0.13M-0.13M0.02M-0.02M
Change in Inventory 0.68M0.71M0.01M0.58M-0.03M-0.03M0.09M-0.03M0.45M0.24M-1.16M-0.85M-0.04M-0.14M-0.05M
Change in Accured Expenses -0.68M3.99M0.48M9.23M-4.65M6.89M6.86M-12.32M4.83M-4.16M-1.66M-3.33M-2.27M2.31M-1.08M
Investing Activities
Capital Expenditures 0.12M0.02M
Cash from Investing Activities -0.12M-0.02M
Financing Activities
Other financing activities 0.74M0.07M0.12M0.16M0.01M0.18M0.80M0.00M0.69M
Debt Issuance and Repayment
Long-Term Debt Issuances 30.00M
Change in Capital Stock
Shares Issued 0.05M0.05M24.66M2.38M26.74M0.47M7.00M14.01M0.14M38.23M
Misc.
Cash from Financing Activities 30.05M0.05M24.15M0.25M2.12M26.63M5.30M0.45M4.28M13.20M0.14M37.53M
Change in Cash -32.53M33.02M-1.14M-38.59M-28.20M-37.98M-37.58M-24.74M8.92M-17.87M-15.88M-10.53M1.16M-12.44M18.75M
Free Cash Flow -32.53M-33.12M-31.19M-38.64M-52.35M-38.21M-37.58M-26.86M-17.71M-23.17M-16.34M-14.81M-12.04M-12.57M-18.79M
Net Cash Flow -32.53M-33.12M-1.14M-38.59M-28.20M-37.96M-37.58M-24.74M8.92M-17.87M-15.88M-10.53M1.16M-12.44M18.75M